Abstract
Fifty-nine patients were treated with cyclosporin A (CsA) eye drops for various diseases. Most patients with severe vernal keratoconjunctivitis responded well to the treatment. Treatment had little or no effect on anterior uveitis (acute and chronic) or on the fate of high-risk corneal grafts. The response of patients suffering from peripheral corneal melting, ocular pemphigoid or Stevens-Johnson syndrome was variable. Among these, some patients responded well to the treatment with CsA drops while others had no detectable clinical benefit. The large differences in the observed treatment responses may be interpreted to indicate that a different pathological mechanism may take place within a group of patients with similar diagnoses and clinical manifestations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
